ISSN 1694-8882 / e-ISSN 1694-8890
Vol. 16, No. 2, 2024 / Pages 36-41

Immune thrombocytopenic purpura in an elderly patient with COVID-19 (clinical case)

Received 23.10.2023
Revised 12.03.2024
Accepted 09.05.2024

Abstract

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by a low platelet count and mucocutaneous bleeding. Many viruses have been identified as autoimmune triggers, including human immunodeficiency virus (HIV), hepatitis C virus (HCV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), parvovirus, rubella, and measles. A rare association with the novel severe acute respiratory syndrome coronavirus, SARS-CoV-2 infection (Covid-19 infection), has been reported. Here we report a case of ITP in an elderly patient caused by a novel coronavirus infection. He demonstrated an inadequate response to IVIG but responded to corticosteroids without serious side effects. Further research is needed to determine optimal therapeutic strategies for ITP in Covid-19 infection

Keywords

immune thrombocytopenic purpura; old age; COVID-19; treatment

Suggested citation

APA Style
Janybek kyzy, A., Adambekova, A., Baidolotova, N., Tursunbekov, M. & Mamatov, S. (2024). Immune thrombocytopenic purpura in an elderly patient with COVID-19 (clinical case). Eurasian Health Journal, 16(2), 36-41. https://doi.org/10.54890/1694-8882-2024-2-36
Copied!
Vancouver Style
Janybek kyzy, A., Adambekova, A., Baidolotova, N., Tursunbekov, M., Mamatov, S.. Immune thrombocytopenic purpura in an elderly patient with COVID-19 (clinical case). Eurasian Health J. 2024;16(2):36-41. https://doi.org/10.54890/1694-8882-2024-2-36
Copied!

References

References in the process of publication